|
asians |
8 |
|
diabetic retinopathy |
8 |
|
ocular surface disease |
8 |
|
severe cutaneous adverse reactions |
8 |
|
stevens–johnson syndrome |
8 |
|
toxic epidermal necrolysis |
8 |
|
macular degeneration |
7 |
|
carotenoids |
5 |
|
optical coherence |
5 |
|
polyunsaturated fatty acid |
5 |
|
saturated fatty acid |
5 |
|
stevens-johnson syndrome |
5 |
|
tomography |
5 |
|
autoimmune disorders |
3 |
|
cancer treatment |
3 |
|
conventional glycemic control |
3 |
|
covid-19 |
3 |
|
graves’ disease |
3 |
|
immune checkpoint inhibitors |
3 |
|
immune-related adverse events |
3 |
|
inflammatory eye disease |
3 |
|
insulin dependent diabetes mellitus |
3 |
|
intense glycemic control |
3 |
|
non insulin dependent diabetes mellitus |
3 |
|
ophthalmic considerations |
3 |
|
pandemic |
3 |
|
thyroid eye disease |
3 |
|
astigmatism |
2 |
|
lenticule extraction |
2 |
|
myopia |
2 |
|
phacoemulsification |
2 |
|
phacovitrectomy surgery |
2 |
|
premium intraocular lens |
2 |
|
smile |
2 |
|
vitrectomy |
2 |
